BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12397793)

  • 1. Multicolor FISH.
    Jalal SM; Law ME
    Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent duplication of Xq27-qter in hematological malignancies revealed by multicolor fluorescence in situ hybridization and multicolor banding.
    MacKinnon RN; Zordan A; Campbell LJ
    Cancer Genet Cytogenet; 2005 Sep; 161(2):125-9. PubMed ID: 16102582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
    Nara N
    Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
    Wang HP; Li GX; Qiao ZH; Wang HW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor fluorescence in situ hybridization characterization of cytogenetically polyclonal hematologic malignancies.
    Davidsson J; Paulsson K; Johansson B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):180-3. PubMed ID: 16337865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
    Kakazu N; Abe T
    Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
    Taniwaki M
    Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
    [No Abstract]   [Full Text] [Related]  

  • 10. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 11. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
    Espinet B; Lloveras E; Solé F
    Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosome analysis of esophageal squamous cell carcinoma cell line KYSE 410-4 by repetitive multicolor fluorescence in situ hybridization.
    Yang Y; Chu J; Wu Y; Luo M; Xu X; Han Y; Cai Y; Zhan Q; Wang M
    J Genet Genomics; 2008 Jan; 35(1):11-6. PubMed ID: 18222404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
    Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
    Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of chromosome aberrations in esophageal cancer cell line KYSE180 by multicolor fluorescence in situ hybridization.
    Wu YP; Yang YL; Yang GZ; Wang XY; Luo ML; Zhang Y; Feng YB; Xu X; Han YL; Cai Y; Zhan QM; Wu M; Dong JT; Wang MR
    Cancer Genet Cytogenet; 2006 Oct; 170(2):102-7. PubMed ID: 17011979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal residual disease in hematology].
    Rák K
    Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.
    Krupp W; Geiger K; Schober R; Siegert G; Froster UG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):32-8. PubMed ID: 15325091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicolor fluorescence in situ hybridization and its application in genetic toxicology].
    Xia Y; Wang X
    Wei Sheng Yan Jiu; 2004 May; 33(3):354-7. PubMed ID: 15211814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split-signal FISH for detection of chromosome aberrations.
    van Dongen JJ; van der Burg M; Langerak AW
    Hematology; 2005; 10 Suppl 1():66-72. PubMed ID: 16188640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
    Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
    Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.